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Abstract
Background: Mentalization Based Therapy (MBT) has yielded promising outcomes for reducing self-harm, although
to date only one study has reported MBT’s effectiveness for adolescents (Rossouw and Fonagy, J Am Acad Child
Adolesc Psychiatry 51:1304–1313, 2012) wherein the treatment protocol consisted of an intensive programme of
individual and family therapy. We sought to investigate an adaptation of the adult MBT introductory manual in a
group format for adolescents.
Methods: The present study is a randomised controlled single blind feasibility trial that aims to (1) adapt the original
explicit MBT introductory group manual for an adolescent population (MBT-Ai) and to (2) assess the feasibility of a trial
of MBT-Ai through examination of consent rates, attendance, attrition and self-harm. Repeated measures ANOVAs were
conducted to examine change over time in independent and dependent variables between groups, and multi level
models (MLM) were conducted to examine key predictors in relation to change over time with self-report self-harm
and emergency department presentation for harm as the primary outcome variables.
Results: Fifty-three young people consented to participate and were randomised to MBT-Ai + TAU or TAU alone. Five
participants withdrew from the trial. Trial procedures seemed appropriate and safe, with acceptable group attendance.
Self-reported self-harm and emergency department presentation for self-harm significantly decreased over time in
both groups, though there were no between group differences. Social anxiety, emotion regulation, and borderline
traits also significantly decreased over time in both groups. Mentalization emerged as a significant predictor of change
over time in self reported self harm and hospital presentation for self-harm.
Conclusions: It was feasible to carry out an RCT of MBT-Ai for adolescents already attending NHS CAMHS who have
recently self-harmed. Our data gave signals that suggested a relatively brief group-based MBT-Ai intervention may be
a promising intervention with potential for service implementation. Future research should consider the appropriate
format, dosage and intensity of MBT for the adolescent population.
Trial registration: NCT02771691; Trial Registration Date: 25/04/2016.
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Background
Self-harm is one of the most prominent risk factors for
suicide [1, 2]. A recent Scottish study reported that one in
six young people had engaged in non-suicidal self-harm
whilst one in nine young people had attempted suicide
[3]. 10–25% adolescents repeat self-harm behaviours
within a year [2, 4]. Adolescents who self-harm are more
likely to experience a wide range of psychosocial problems
later in life [5]. Self-harm often occurs within the context
of a wider, complex mental health presentation, involving
the interaction of a variety of social, psychological and
cultural factors [4], most commonly with depressive dis-
orders, posttraumatic stress disorder, substance abuse, and
borderline personality disorder (BPD) [2, 6, 7]. A majority
(62.4%) of those who die by suicide aged 35 years and
younger were found to have presented to health services
the year preceding their death [8]. This provides signifi-
cant potential for early intervention to decrease self-harm
and suicide prevalence, and also to prevent the escalation
of parallel emotional distress and functional impairments.
Difficulties such as emotion dysregulation and decreased
social functioning are predictive of self-harm in young
people [9, 10]. It has also been suggested that self-harm
can be understood in the context of reduced and or a
temporary loss of mentalizing capacity, particularly in the
context of interpersonal stress. Mentalizing is the mental
activity that enables us to perceive and interpret human
behaviour in terms of intentional, motivational and emo-
tional mental states (e.g., needs, desires, feelings, beliefs,
goals, purposes, and reasons) [11, 12]. Self-harm is in part
presumed to be the result of a failure to make sense of
social experience, resulting in reduced adaptive coping
and impulsive behaviours including self-harm [12, 13].
Indeed, mentalization was recently found to be the only
independent variable to predict higher risk of suicide in
psychiatric adult inpatients [14].
A number of approaches with little to no evidence are
currently considered to be best-practice within clinical
settings [15]. The need to further develop and replicate
trials for self-harm in adolescence has been repeatedly
highlighted throughout the literature [16–19]. Two recent
systematic reviews evidenced promising effects for three
therapeutic interventions namely cognitive behavioural
therapy, dialectal behaviour therapy (DBT), and MBT [17,
19]. MBT, which was initially developed for the treatment
of adults with a diagnosis of borderline personality dis-
order (BPD), directly addresses the fragile mentalizing
capacity that is a core feature of BPD [20] and other
complex pathology. Within an adult BPD population,
MBT reduced self-harm, emotional distress and inpatient
stays, and improved social function in comparison to
treatment as usual [21] with continued improvements at
18 months [22]. MBT was also associated with reduced
self-harm in an adult outpatient setting [23].
In relation to the adolescent population, MBT-A was
more effective than treatment as usual for young people
who self-harm [13]. The treatment protocol involved
weekly individual MBT-A sessions and monthly MBT
family therapy (MBT-F) delivered over 12months. In a
non-controlled pilot, self-reported self-harm reduced in
the context of an intensive MBT group programme for
adolescents with BPD or subthreshold BPD that in-
cluded introductory psychoeducational group sessions,
34 sessions of MBT group-therapy and 7 sessions of
MBT-parents (MBT-P) [24]. Psychoeducational group
sessions aim to increase understanding of mentalizing,
emotion regulation and so on, whilst group therapy
sessions are more process-focussed, aiming to facilitate
mentalizing between group participants. It is not known
which modalities of MBT (individual, group, family,
parents) are most effective or instrumental in any
observed clinical change. Furthermore, little is known
about the required intensity of intervention.
In our own version, we adapted the introductory MBT
group with adults (MBTi) [25] for use with an adolescent
population (MBT-Ai). A key aim is the development of
MBT knowledge about underlying principles and concepts
of mentalization. Whilst MBTi for previous trials was
designed as a psychoeducation precursor to a combination
of MBT individual and group therapy, our MBT-Ai
programme incorporates a number of experiential tasks
and role plays to encourage the application of mentali-
zation principles to common interpersonal dilemmas.
The present study aims to evaluate the feasibility and
effects of 12 week MBT-Ai for the reduction of self-
harm and crisis presentations in a group of young people
already receiving treatment within specialist NHS Child
and Adolescent Mental Health Services (CAMHS).
Methods/design
We report on the proportion of potential participants who
consented to participate in the trial, group attendance,
ability to follow-up participants, trial withdrawals, and
serious adverse events. We also report on the clinical
characteristics of the trial participants at entry, end of
treatment and follow-up, including any group diffe-
rences. Study methodology will be reported in accordance
with the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) statement and guide-
lines [26]. Further information about the development
of the group protocol and trial methodology is avail-
able elsewhere [27].
Study design
This study is a two-arm, single (rater) blind, randomised
controlled trial registered with ClinicalTrials.gov (Trial
registration: NCT02771691).
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Setting
The recruitment area serves a population of appro-
ximately 160,000 young people under 18 years and pro-
vides a range of outpatient and more specialist services.
Staff from Tier 4 services, which include day pro-
grammes and assertive outreach teams, have received
training in Adaptive Mentalization-Based Integrative
Treatment (AMBIT) [28]. Four trained MBT therapists
from this service developed and piloted the MBT-Ai
group manual under supervision provided by the Anna
Freud Centre.
Participants
Inclusion criteria were as follows: (1) Aged 12–18 years
(2) self-harm behaviour in the past 6 months (3) in
receipt of CAMHS treatment (4) competent and willing
to provide written, informed consent. Exclusion criteria
were: (1) severe learning disability or pervasive develop-
mental disorder (2) acute psychotic episode (3) eating
disorder in the absence of self-harm (4) non-English
speaking (5) current involvement in other ongoing treat-
ment research.
Procedure
Research assistants blind to randomisation conducted
assessments of primary and secondary outcomes and
liaised regularly with the relevant clinical teams. Masking
was maintained using a wide range of measures. Trial
unblindings were reported to the Trial Manager who
implemented corrective action if necessary. Key clinicians
identified potential participants, offered them a participant
information sheet and invited them to take part. Self-
referrals were also accepted. The treating clinicians
confirmed they met criteria and that all young people had
capacity to consent.
We applied the principle of direct consent for all
potential participants. During the recruitment/consenting
process the researcher ensured that the young person was
fully informed of the randomisation process and their
chances of receiving MBT-Ai group therapy.
Once written consent had been obtained, baseline
measures were completed. Primary and secondary out-
comes were carried out within a single 30-min session at
each time point wherever possible. Case note review was
completed at the end of treatment.
Participants were withdrawn from the trial if they
withdrew consent. A distinction was made as to whether
the individual was withdrawing consent from further
trial treatment only or withdrawing from trial treatment
and follow-up.
Randomisation/treatment allocation
Randomisation (at the individual level) was independent
and concealed, using randomised-permuted blocks adjusted
to permit access to group treatment without undue delay.
Group allocation remained concealed until completion of
self-report ratings.
Study arms
Mentalization based treatment for adolescents (MBT-Ai)
group therapy
Key aims of MBT-Ai were to encourage emotional literacy;
introduce concepts of mentalization, attachment and emo-
tion regulation; facilitate reflection on interpersonal rela-
tionship patterns; and explore how these concepts affect
emotional expression, behaviour and mental health. Up to
12 sessions of MBT-Ai were delivered by trained MBT
therapists, who were highly experienced clinical psycholo-
gists under the supervision of an MBT accredited super-
visor, to up to 10 young people per group. Our groups
were 1.25 h long, and always started with a warm-up
exercise to encourage group participation. We used
worksheets, DVD clips and specific case material
providing real life age-appropriate examples as a way
to enhance learning and facilitate group discussion.
The application of mentalization techniques to common
daily dilemmas was encouraged throughout. Technical
language was simplified where possible e.g. “avoidant
attachment” was replaced with “distant style of re-
lating”. The manual is available from the corresponding
author on request.
Fidelity to protocol and adherence to the principles of
MBT was checked by means of audiotape ratings which
were rated by an MBT accredited supervisor using an
adherence tool adapted for our MBT-Ai group format
and fed back into supervision.
Treatment as Usual (TAU)
TAU was delivered according to national and local service
protocols and guidelines. Given that we recruited from a
population already attending either tier 3 or tier 4
CAMHS, the young people may be experiencing a number
of difficulties in addition to self-harm behaviour. Depend-
ing on the presenting problems, treatment could therefore
consist of any combination of key worker input, psycho-
logical/psychosocial intervention and medication. Local
services consist of multidisciplinary teams that may include
child and adolescent psychiatrists, social workers, clinical
psychologists, community psychiatric nurses, occupational
therapists and community mental health workers. Tier 3
services are offered in community mental health settings
on an outpatient basis. Tier 4 provides tertiary level
services including intensive community treatment, day
programmes and an inpatient unit. In order to estab-
lish the parameters of the TAU package [29], service use
was measured using an adapted version of the Client
Service Receipt Inventory (CSRI) [30] which provided a
summary of health services accessed by the young people
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over the study period. Referrers were not asked to with-
hold any treatment as this was considered unethical.
Data collection
We collected data about the proportion of young people
who consented to randomisation, study withdrawal
and the occurrence of any serious adverse events. An
event was considered to be a serious adverse event if
it resulted in one of the following outcomes: a) death
b) was life-threatening c) inpatient hospitalisation or
prolongation of existing hospitalisation d) persistent
or significant disability or incapacity. For the MBT-Ai
arm only, group attendance and attrition rates were
also monitored.
Outcome measures
Our primary outcome was self-harm post-treatment as
assessed by:
1. The self-harm subscale of the Risk-Taking and
Self-Harm Inventory for Adolescents (RTSHI) [31]:
a self-report measure designed to assess adolescent
risk-taking and self-harm in community and clinical
settings. In the original study, both self-harm and
risk-taking factors of the RTSHI demonstrated high
internal consistency, test-retest reliability and
sufficient validity in youth.
2. Self-harm related hospital use as reported by
emergency department presentation in NHS
electronic records.
Participants also completed the following self-report
measures:
 Risk-taking as measured by the risk-taking subscale of
the Risk-Taking and Self-Harm Inventory (RTSHI) [31].
 Emotional distress (anxiety and depression) as
measured by the Revised Child Anxiety and
Depression Scale (RCADS) [32]. The RCADS
has evidenced reliability and validity in both clinical
[33] and school-based samples of children and
adolescents [34, 35].
 Mentalization as measured by the self-report
Reflective Functioning Questionnaire for Youths
(RFQ-Y). This measure has demonstrated
adequate internal consistency, convergent validity
and reliability in an adolescent sample [36].
 Emotion regulation as measured by the Difficulties
in Emotion Regulation Scale (DERS) [37]. This
measure has evidenced high internal consistency,
adequate validity and good test-retest reliability
in young adults [37] and adolescents [38].
 Interpersonal sensitivity as measured by the
Interpersonal Sensitivity Measure (ISM) [39]. Validity
and reliability has been evidenced in populations
diagnosed with depression and anxiety [39, 40].
 Borderline Traits as measured by the 11-item short
version of the Borderline Personality Features Scale
for Children (BPFSC) [41]. In the original study,
satisfactory construct and criterion validity in
adolescent samples were established.
 Attachment as measured by the 12-item short
version of the Experiences in Close Relationships
Scale–Revised Child version (ECRS-RC), shown to
have excellent validity and reliability in youth
samples [42].
All measures were administered blind by the research
assistants at baseline, 12, 24 and 36 weeks. In addition, the
RFQ-Y was administered at 6, 18 and 30 weeks. For self-
harm related emergency department use, the research
assistants reviewed NHS electronic records after the last
face to face assessment had been conducted in order to
maintain blinding. Details of all crisis service use (e.g.
presentation at emergency department or other mental
health emergency service provision and related hospital
in-patient admissions) were recorded on a pre-specified
proforma along with a description of the self-harm and
confirmation that the hospital admission was in relation
to that self-harm.
Power and statistical analysis
In this feasibility trial the sample size was not predeter-
mined. We aimed for sufficient data to report on response
rates, follow-up rates, safety information and attrition, as
well as the clinical characteristics of our study population
at the beginning and end of the trial and follow-up.
The majority of our reporting is descriptive. However, in
order to assess whether the receipt of MBT-Ai plus TAU
compared to TAU alone, leads to reduced self-harm and
crisis presentations we also carried out intention-to-treat
analyses to determine indicative treatment effects on the
primary and secondary outcome measures, adjusting for
pre-specified baseline covariates. A correlation matrix was
conducted to explore the outcome measures to see if there
were strong treatment signals within these sub scales.
Subsequently, three multi level models (MLM) were
constructed, adjusting for baseline measures to assess the
treatment effects on the primary and secondary outcome
measures and the key predictors of the trajectories of
these treatment effects over time.
Results
Demographic and clinical data
There were 73 referrals to the trial. Of these, 53 (73%)
young people consented to participate and were randomised
to either MBT-Ai plus TAU or TAU alone. Reasons for
non-randomisation are provided in Fig. 1.
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Fig. 1 Consort diagram
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At entry to the study, there were no significant between
group differences on demographic or service usage
variables (see Table 1). Our sample was slightly older than
the original MBT trial for adolescents [13] with a mean
age of 15.5 years compared to 14.7 years. Our population
was 77% female compared to 85% in the original trial. The
MBT-Ai plus TAU group reported significantly higher
scores on the BPD total score (t(46) = − 2.016, p = .050) as
assessed on the BPFSC. Using the recommended cut-off
for this scale [41] 55% of participants in the treatment
arm warranted further assessment for borderline personal-
ity disorder compared to only 15% of the control arm.
There were no other significant differences on baseline
measures between the two groups. The mean score of
self-reported self-harm at baseline was 27.6 (SD = 11.9)
compared to 15.78 (SD = 9.84) reported for a clinical sam-
ple recruited to an RCT for self-harm reported in the ori-
ginal validation paper [31]. The higher levels in our
sample may reflect rises in help-seeking for self-harm be-
haviour reported, particularly for young women, over the
last decade (e.g. [3]). Not surprisingly since we recruited a
group who were already receiving treatment from
CAMHS, the mean total score for both groups on the
RCADS placed our total population firmly within the clin-
ical range [33]. Given that our inclusion criteria were be-
haviourally rather than diagnostically informed, we did
not collect information about medication at baseline.
However, whilst contact with a psychiatrist does not
equate to being prescribed medication, our service usage
data highlighted that 16 young people (33%) had had one
or more appointments with psychiatry, eight young people
from each arm.
Five participants withdrew from the trial. Post-
treatment we collected self-report data from 50% partici-
pants who remained in the trial and 42% of those at 12
week follow-up. Patient records data reporting self-harm
related hospital use taken at 36 weeks was available for
all trial completers. There were 5 adverse events involv-
ing 4 young people, but none of these were considered
to be trial related.
Twenty-six young people were randomised to the MBT-
Ai plus TAU arm of the trial and were offered the group
intervention. The average number of sessions attended
was 5.3 (ranging from 0 to 12). Six (27.3%) young people
did not attend any sessions; five (22.7%) attended 1–6 ses-
sions; and 11 (50%) young people attended 50% or more.
Table 1 Demographic, Service Use and Clinical Characteristics at Baseline
Characteristics at Baseline TAU MBT-A
Female, n/N (%) 21/26 (80.8) 17/22 (77.3)
Age, years, mean (SD) 15.7 (1.4) 15.4 (1.3)
Living with parent/guardian or other family, n/N (%) 22/26 (84.6) 18/22 (81.8)
Enrolled in formal educationa, n/N (%) 22/26 (84.6) 17/22 (77.3)
Ethnicity white Scottish, n/N (%) 18/26 (69.2) 15/22 (68.2)
Socioeconomic status = <60th percentile, n/N (%) 11/26 (42.3) 10/22 (45.5)
Number of appointments 6-months pre-treatment, mode (range) 14.5 (1–80) 11.0 (2–81)
Number of appointments between treatment and 24-week follow-up, mode (range) 9.0 (0–104) 17.0 (0–108)
Years since initial referral to CAMHS, n/N (%)
< 1 year 7/26 (26.9) 9/22 (40.9)
1–2 years 13/26 (50.0) 3/22 (13.6)
2–3 years 3/26 (11.5) 5/22 (22.7)
3 years + 2/26 (7.7) 5/22 (22.7)
Unknown 1/26 (3.8) 0/22 (0)
Self-reported self-harm at baseline 26.8 (11.8) 28.3 (11.9)
Self-reported risk taking at baseline 12.7 (7.0) 12.6 (9.3)
Self-harm related A + E presentation 6 months pre-baseline, mean (range) 1.08 (0–7) 0.73 (0–4)
RCADS 79.8 (24.9) 91.1 (22.0)
RFQ 8.1 (0.8) 8.3 (0.8)
DERS 133.8 (21.9) 140.4 (17.9)
ERC 6.9 (1.9) 7.7 (2.2)
BPD 28.4 (5.6)* 32.0 (6.9)*
ISMb 82.5 (12.3) 85.9 (7.4)
aIncludes high school and/or college; bonly 18 TAU and 13 MBT completed baseline assessment *significant at p ≤.05
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Changes in self-harm & clinical variables
Intent to treat (ITT) analytic strategy was employed in
order to reduce bias in treatment effects resulting from
missing data. Missing values at an item-level of < 15%
were imputed based on a multiple imputation model. Last
observation carried forward was the conservative imput-
ation strategy used for questionnaire level missing data.
Normality of distributions was tested using the
Shapiro-Wilk test. There was indication that three of the
RTSHI scores (RT at post, 12- and 24-week follow-up)
were skewed, but none of the SH measures. In order to
examine trajectories over time we conducted multi-level
modelling (MLM) to examine change over time (from
baseline to post-treatment and follow-up) with self-
reported self-harm and ED admissions due to self-harm
as dependent variables and baseline self-reported risk-
taking, emotion regulation and mentalization entered as
independent fixed effect predictors.
There was a significant decrease in both self-reported
self-harm and emergency department presentation but
not risk-taking behaviour from baseline to post-treatment,
with an observed power of 0.767 and 0.845 respectively.
See Table 2 for results. However, there was no difference
in change over time between groups. In order to detect a
small effect over time and between group in our sample
power of 0.875 would be needed for self reported self
harm and 0.998 for emergency presentations.
Change over time was also observed on several of the
self-report questionnaire variables, namely social anxiety,
emotion regulation and borderline personality features,
as illustrated in Table 3. Similarly, there were no signifi-
cant group differences over time.
Interaction between clinical variables
In order to explore any further signals about interactions
between our variables, non parametric bivariate corre-
lations were examined between questionnaire outcomes
and both self-reported and hospital presentation self-harm
outcomes at baseline and at follow-up. Reported self-harm
at follow-up was associated with baseline reported
self-harm, risk-taking and poor emotion regulation.
Emergency department presentations at follow-up were
associated with baseline reported self-harm, emergency
department presentations and reflective function at base-
line (Table 4).
Trajectories of treatment effects: self-harm
We utilized multi-level modelling (MLM) conducted
with R (R Development Core Team, 2017) to examine
change over time (from baseline to post-treatment and
follow-up) with self-reported self-harm and ED admis-
sions due to self-harm as dependent variables and base-
line self-reported risk-taking, emotion regulation and
mentalization entered as independent fixed effect pre-
dictors. There are several advantages to utilizing MLM
that make the data analytic method appropriate for the
current investigation. One of these benefits includes the
ability for data to be modelled at two different levels:
Level 1 describes within-individual change over time
(e.g., trajectory of self harm and ED admissions), and
Level 2 allows the prediction of between individual-level
differences in this change (e.g., group). An additional
advantage to using MLM is that the approach accounts
for missing data at Level 1 by estimating the trajectory
using all existing data for that participant. This benefit is
crucial in any longitudinal data analyses so as not to
exclude participants with partial data on the dependent
variables. In addition to the approach’s benefits, MLM
allows to control for baseline scores of each measure
when investigating change in each construct over time.
Prior to conducting the proposed MLM models, the
appropriateness of using this analytic approach was
examined by building two null models. Each null model
separately tested each of our dependent variables (i.e., self
reported self harm and ED admissions due to self-harm)
to determine the potential for correlated error and the
Table 2 Emergency department presentation and self-reported self-harm, Change over time
Pre-treatment Post-treatment 12-wk follow-up 24-wk follow-up Spher Change
over time
Time X
Group
Continuous
measure
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
W MS F MS F
Self-Harm subscale
(RTSHI) Mean (SD)
26.82
(11.80)
28.32
(11.89)
23.12
(12.28)
26.00
(12.57)
22.93
(12.35)
24.41
(12.52)
22.74
(13.04)
24.50
(13.88)
.518*** 225.02 6.29** 7.17 .201, NS
Risk Taking subscale
(RTSHI) Mean (SD)
12.66
(7.02)
12.61
(9.28)
12.88
(8.28)
12.78
(9.64)
13.21
(8.52)
12.82
(9.94)
13.29
(8.27)
12.65
(10.25)
.601*** 1.406 .210,
NS
.888 .133,
NS
Total (RTSHI) Mean (SD) 39.48
(16.94)
40.93
(18.08)
36.00
(18.80)
38.78
(19.65)
36.14
(19.67)
37.24
(20.22)
36.03
(19.91)
37.16
(21.90)
.477*** 183.34 2.83,
NS
10.01 .154,
NS
Self-Harm ED
Presentation Mean
(range)
1.08
(0–7)
0.73
(0–4)
0.23
(0–2)
0.36
(0–2)
0.54
(0–3)
0.23
(0–2)
0.35
(0–4)
0.09
(0–1)
.527*** 6.49 9.55*** 0.84 1.24,
NS
Abbreviations: ED Emergency Department, RTSHI Risk-Taking and Self-Harm Inventory
*p < .05,**p < .01,***p < .001
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Table 3 Self-report variables, change over time
Pre-treatment Post-treatment 12-wk follow-up 24-wk follow-up Spher. Change
over time
Time X Group
Continuous
measure
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
TAU
(n = 26)
MBT-A
(n = 22)
W MS F MS F
RCADS (SP) 18.68
(6.29)
19.65
(5.8)
17.72
(6.35)
19.49
(5.81)
18
(5.97)
19.38
(6.25)
18.81
(6.01)
18.96
(6.72)
.35*** 4.36 .856, NS 8.50 1.66, NS
RCADS (PD) 14.65
(6.37)
16.69
(6.13)
12.8
(5.99)
15.73
(6.36)
13.85
(6.18)
14.23
(6.31)
13.46
(6.47)
14.92
(5.93)
.19*** 48.25 2.755, NS 23.91 1.37, NS
RCADS (MD) 19.12
(6.35)
21.12
(4.43)
18.15
(6.57)
20.39
(4.74)
17.81
(6.65)
19.89
(5.64)
18.49
(6.96)
20.07
(5.72)
.37*** 21.83 2.41, NS 1.55 .171, NS
RCADS (SA) 8.49
(4.36)
10.3
(5.5)
6.98
(4.03)
9.96
(5.64)
7.21
(4)
9.51
(5.47)
7.25
(3.73)
9.69
(5.54)
.31*** 18.92 4.17* 4.73 1.04, NS
RCADS (GA) 10.52
(3.95)
12.73
(3.57)
9.77
(3.72)
12.64
(4.09)
10.27
(3.73)
12.18
(4.2)
10.38
(3.82)
12.55
(3.96)
.22*** 3.67 .523, NS 3.76 .534, NS
RCADS (OC) 8.33
(3.08)
10.59
(3.4)
7.73
(3.34)
9.78
(3.48)
8.29
(3.26)
9.2
(4.07)
8.38
(3.53)
9.37
(3.87)
.34*** 8.21 1.62, NS 8.88 1.75, NS
RCADS Anx 71.46
(22.74)
80.48
(19.99)
65.42
(22.4)
78.21
(21.48)
67.14
(22.05)
76.56
(25.24)
68.4
(21.61)
77.55
(24.91)
.151*** 347.28 2.15, NS 73.78 .457, NS
RCADS Inter 79.79
(24.88)
91.07
(22.04)
73.15
(24.24)
87.99
(23.67)
75.43
(24.18)
85.76
(28.05)
76.78
(23.84)
86.93
(27.58)
.151*** 480.53 2.27, NS 109.16 .515, NS
RFQY ScaleA 4.18
(0.49)
4.19
(0.51)
4.18
(0.49)
4.29
(0.72)
4.21
(0.53)
4.46
(0.79)
4.14
(0.61)
4.36
(0.71)
.404*** .287 1.40, NS .210 1.03, NS
RFQY ScaleB 3.96
(0.45)
4.12
(0.38)
3.96
(0.52)
4.05
(0.32)
3.95
(0.55)
4.1
(0.38)
3.92
(0.56)
4.08
(0.33)
.227*** .037 .353, NS .022 .212, NS
RFQY Total 8.14
(0.79)
8.31
(0.76)
8.14
(0.78)
8.34
(0.82)
8.16
(0.76)
8.56
(0.88)
8.06
(0.79)
8.44
(0.77)
.389*** .292 .81, NS .266 .736, NS
DERS NA 21.42
(5.06)
23.59
(5.24)
20.23
(6.11)
21.32
(5.5)
20.62
(6.54)
21
(5.49)
21.38
(7.94)
21.95
(5.56)
.667** 40.38 3.27* 9.55 .773, NS
DERS Goal 21.58
(2.84)
21.82
(2.79)
20.85
(3.29)
20.95
(3.2)
20.5
(2.96)
20.95
(3.24)
20.42
(3.49)
21.45
(3.08)
.489*** 13.09 2.22, NS 2.93 .495, NS
DERS Impulse 22.38
(4.84)
23.59
(4.85)
21.88
(5.3)
22.82
(5.21)
21.33
(5.54)
22.33
(5.54)
21.27
(5.1)
23.5
(5.27)
.800 10.67 1.72, NS 4.36 .704, NS
DERS Aware 20.92
(4.51)
21.5
(4.82)
21.76
(4.62)
21.5
(4.03)
21.31
(4.68)
20.77
(4.45)
20.92
(4.77)
21.41
(4.17)
.522*** 4.46 .612, NS 5.14 .705, NS
DERS Strat 30.33
(6.89)
31.86
(6.06)
29.61
(7.24)
30.18
(6.17)
29.12
(7.47)
30.04
(6.94)
29.27
(7.86)
30.82
(6.8)
.674** 26.00 2.89* 3.46 .385, NS
DERS Clarity 17.21
(4.71)
18.05
(3.37)
16.48
(4.7)
17.91
(4.29)
17.03
(4.32)
17.59 (4) 17.95
(5.46)
18.14
(4.02)
.279*** 12.26 1.26, NS 5.82 .60, NS
DERS Total 133.85
(21.9)
140.41
(17.9)
130.81
(23.29)
134.68
(20.18)
130.05
(23.83)
132.7
(21.45)
131.37
(23.67)
137.28
(19.88)
.685*** 365.05 3.22* 48.80 .431, NS
ECRS Anxiety 3.04
(1.53)
3.74
(1.78)
3.09
(1.79)
3.41
(1.81)
2.82
(1.87)
3.33
(1.76)
2.81
(1.83)
3.5
(1.92)
.367*** 1.36 2.07, NS .598 .913, NS
ECRS Avoid 3.85
(0.65)
3.92
(0.88)
3.84
(0.46)
3.83
(0.79)
3.85
(0.5)
3.8
(1.04)
3.81
(0.56)
3.9
(1.05)
.299*** .050 .153, NS .098 .301, NS
ECRS Total 6.89
(1.85)
7.66
(2.24)
6.94
(1.99)
7.25
(2.12)
6.67
(2.13)
7.13
(2.31)
6.62
(2.09)
7.4
(2.52)
.334*** 2.044 1.52, NS 1.152 .859, NS
BPF total 28.42
(5.59)
32.05
(6.86)
27.5
(5.88)
29.59
(6.91)
27.42
(6.26)
28.77
(6.76)
27.42
(6.33)
29.09
(6.55)
.418*** 68.37 5.35** 17.87 1.40, NS
Abbreviations: RCADS Revised Child Anxiety and Depression Scale (SP social phobia, PD panic disorder, MD depression, GA generalized anxiety, SA separation
anxiety, OC obsessive-compulsive disorder, Anx anxiety total, Inter internalizing total), RFQY Reflective Functioning Questionnaire for Youths, DERS Difficulties in
Emotion Regulation Scale (NA nonacceptance, Goal difficulties engaging in goal directed behavior, Impulse impulse control difficulties, Aware lack of emotional
awareness, Strat limited access to emotion regulation strategies, Clarity lack of emotional clarity), ECRS Experiences in Close Relationships Scale–Revised Child
version, BPF Borderline Personality Features Scale for Children
*p < .05,**p < .01,***p < .001
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need for linear mixed modelling. In both cases, the intra-
class correlation coefficient (ICC) was significant, indicat-
ing that a multilevel model was appropriate and necessary.
For self reported self harm, the correlation in the con-
struct across time within participants was 0.31 and for ED
admissions, it was 0.58.
We specified Level-1 intercepts and slopes as random
given expected within-person variability in baseline scores
and change in constructs over time. We tested a total of
three models. The trajectory models were first estimated
to evaluate systematic linear changes over time.
For every model that was tested, the intercepts for self
reported self harm and Hospital admissions due to self-
harm were significant, indicating that baseline scores for
each of these variables was different across individuals
(see Table 5).
Model 1 for for self reported self harm and Hospital
admissions due to self-harm shows significant change
Table 4 Correlation Matrix: All self-harm
Self-harm
BL
Self-harm
FU
RCADS
BL
RFQY
BL
DERS
BL
ECR
Anxiety BL
ECR
Avoidant BL
BPF
BL
Risk-
taking BL
Hosp. Self-
harm BL
Hosp. Self-
harm FU
Self-reported Self-harm BL 1 .814** .267 −.150 .392** .194 .185 .048 .513** .337* .308*
Self-reported Self-harm FU 1 .117 −.212 .332* .108 .082 .129 .460** .229 .282
RCADS BL 1 .365* .522** .522* .506** .569** .055 −.074 .007
RFQY BL 1 −.046 .163 .192 .341* −.150 −.433** −.400**
DERS BL 1 .388** .285* .375** .194 .068 .003
ECR Anxiety BL 1 .335* .280 .035 .003 .052
ECR Avoidant BL 1 .142 −.012 .128 .156
BPF BL 1 .133 −.327* −.248
Risk-taking BL 1 .000 .029
Hosp. Self-harm BL 1 .847*
Hosp. Self-harm FU 1
Abbreviations: BL Baseline, FU follow-up, RCADS Revised Child Anxiety and Depression Scale, RFQY Reflective Functioning Questionnaire for Youths, DERS
Difficulties in Emotion Regulation Scale, ECRS Experiences in Close Relationships Scale–Revised Child version, BPF Borderline Personality Features Scale for
Children, Hosp. Self-Harm hospital related self-harm
*p < .05,**p < .01,***p < .001
Table 5 Results of MLM of self reported self harm and self harm related hospital admissions
Model1 Model 2 Model 3
Self harm
Intercept 26.83 (1.77)*** 14.60 (3.63)*** 34.53 (10.88)**
Time −0.66 (0.15)*** −0.63 (0.12)*** −0.65 (0.12)***
Baseline self harm 0.51 (0.08)*** 1.53 (0.33)***
Risk taking 0.77 (0.08)*** 0.60 (0.08)***
Emotion regulation 0.14 (0.02)*** 0.12 (0.02)***
Mentalization 2.83 (1.25)*
mentalization x BL SH −0.16 (0.03)**
Log likelihood − 928.32 −852.20 − 848.09
AIC 1864.65 1718.40 1714.19
ED admissions
Intercept 0.46 (0.16)* 0.48 (0.31) 1.31 (0.82)
Time −0.07 (0.02)* − 0.07 (0.02)** − 0.07 (0.02)*
Baseline self harm 0.04 (0.02)** 0.04 (0.01)**
Risk taking −0.02 (0.01)* −0.03 (0.01)*
Mentalization −0.21 (0.09)*
Log Likelihood − 397.122 −397.15 − 395.91
AIC 802.24 806.66 805.82
Values in parentheses represent standard errors. Significance: ***p < .001; **p < .01; * p < .05
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over time. Model 2 adds significant baseline predictors
of baseline self harm, risk taking and emotion regulation
to the model demonstrating their significant contri-
bution for both self reported self harm and Hospital
admissions due to self-harm.
In the final model 3, while controlling for the effects
of self harm at baseline, self reported self harm followed
a linear trajectory with scores decreasing over the course
of time (β = − 0.66, SE = 0.15, p < .001). Risk taking was
significantly related to the construct’s linear trajectory
(β = 0.77, SE = 0.08, p < .001); emotion regulation (β =
0.14, SE = 0.02, p < .001) and mentalization (β = 2.83,
SE = 1.25, p < .001) was associated significantly with self
reported self harm. Furthermore, there was a significant
interaction between baseline or pre treatment self harm
and mentalization (β = − 0.16, SE = 0.04, p < .001).
Hospital admissions due to self harm followed a quad-
ratic trajectory with scores decreasing over time (β = − 0.07,
SE = 0.02, p = .009). Risk taking was significantly related to
the construct’s linear trajectory (β = − 0.03, SE = 0.01,
p = .01) and mentalization (β = − 0.21, SE = 0.08, p = .01)
was associated significantly with reduced ED admissions
self harm.
Discussion
MBT-A has shown promising effects [13]. However it
is not known which MBT modality (individual, group,
family), or combination of modalities, is most effect-
ive, nor how long or intensive therapy needs to be
order to confer benefit.
We found that a pilot RCT of group-based MBT-Ai to
reduce self-harm is both feasible and acceptable to
participants. Clinicians expressed significant interest in
referring to the trial, perhaps reflecting a lack of viable
treatment options for these young people. Our broad
inclusion criteria may also have contributed to our
successful recruitment strategy, facilitating easy referral
from clinicians. Not surprisingly for a clinical sample,
our population experienced high levels of distress and
self-harm behaviour. Over half of the sample warranted
further assessment of borderline personality features on
the basis of their scores on a self-report measure. None-
theless, having recruited on the basis of self-harm be-
haviour from all teams within CAMHS, our population
was somewhat heterogeneous. Ensuring that young
people understood that randomisation may result in no
additional treatment seemed to mitigate against any un-
due attrition from the control group. During a previous
pilot phase young people had expressed a strong pre-
ference for groups to have closed membership, so a major
challenge was to ensure that pre-randomisation pro-
cedures occurred quickly enough to allow the groups to
begin in a timely manner.
In total we ran three separate groups. MBT-Ai group
attendance was adequate, although 27% of participants
randomised to active treatment attended no sessions at
all. This perhaps reflected either an ambivalence about
seeking help for self-harm even within a cohort already
receiving treatment from CAMHS, or the impulsivity of
this population. However, half of those randomised to the
MBT treatment arm attended more than 50% of sessions,
which is comparable to the completed RCT of MBT-A
[13]. We were able to follow-up 50% of our participants at
12 weeks and retain most of these (42% total) at 24 weeks.
Again, this is similar to reports from other recent trials of
self-harm interventions for adolescents [43].
Both self-reported self-harm and self-harm related
hospital use reduced over time. There was no difference
between groups but as a pilot study it was not adequately
powered to detect small effects. In addition, for this pilot,
we placed no restriction on TAU. We did collect service
information in order to characterise routine clinical care
[29]. We subsequently noted that 26% of the TAU alone
group received a 7-week Distress Tolerance group inter-
vention, based on the principles of DBT. DBT for adoles-
cents who self-harm showed the largest effect sizes in a
recent meta-analysis [19] and there is considerable overlap
between DBT and MBT. Furthermore, 19% of participants
were referred from Tier IV services, whose staff had pre-
viously been trained in AMBIT [28]. TAU for some
young people might therefore consist of mentalization-
influenced intervention. Further consideration should
be given to the control condition for any definitive trial.
However, further analysis using data from the whole
sample gave promising signals that were consistent with
mentalization theory. Emotion regulation, reflective
function and the interaction between reflective function
and pre- treatment self-harm emerged as significant
predictors of a reduction in self-reported self-harm and
reflective function alone predicted reduced hospital
presentation for self-harm independent of randomi-
sation. Furthermore, measures of social anxiety, emotion
regulation and borderline features all also demonstrated
change over time in the expected direction. Multi-level
modelling further demonstrated that baseline self-harm,
risk-taking and emotion regulation influenced change
over time on both self-harm outcomes. Moreover, once
these had been taken into account, self-reported menta-
lization had a bigger effect than the other variables.
Additionally, multi-level modelling indicated that men-
talization had an interaction effect with baseline self-
harm. The emerging picture suggests that changes in
mentalization may influence self-harm outcomes, war-
ranting further investigation of the full MBT programme
for this population as well as briefer mentalization-
based interventions such as MBT-Ai in a fully powered
definitive trial.
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Another limitation is that we did not use an
interview-based measure of self-harm. This was a de-
cision informed largely by resource limitations, whilst
acknowledging that different measurement methods for
assessing self-harm result in widely disparate preva-
lence rates [18]. We did additionally assess self-harm
related hospital use through examination of patient re-
cords. This ensured that we were able to collect at least
one main variable for all participants who remained in
the study.
We followed our adapted treatment manual which is
available on request from the authors, ensuring repli-
cability, and took steps to ensure fidelity to the manual
and to principles of MBT. We report on attrition and,
importantly, serious adverse events in addition to our
main outcome variables relating to self-harm, providing
a comprehensive account of any potential unwanted
consequences of our intervention.
The other completed [13] and ongoing [44] trials of
MBT-A offer far more intensive, multi-modal thera-
peutic programmes. A previous meta-analysis noted that
those interventions with more substantial treatment
‘dosage’ were more successful [19]. On the other hand,
the relative brevity of our intervention may have been a
positive for many young people who may have been
reluctant to participate in a year long programme. A
second consideration is the degree to which an MBT
intervention needs to deliver a skills based training
versus a more traditionally therapeutic programme. One
of our adaptations to the adult MBT manual was to
include more experiential exercises and more focus on
applying MBT skills in daily life, with psychoeducation
remaining a significant component of our programme. It
may well be that a more therapeutic focus, in group or
individual format, is required, particularly for those
with more entrenched difficulties. On the other hand,
our skills based approach appeared well suited to our
adolescent population, many of whom had complex
presentations. The more efficient delivery minimises re-
quired service resources. In the UK, CAMHS are
known to be under considerable pressure, stretched for
resources and frequently struggling to meet demand.
Comparatively brief interventions translate into feasible
practice. Given that differential effect sizes seemed to
indicate that interventions with strong family compo-
nents worked best [19], a potential modification would
be to incorporate MBT sessions for parents/caregivers.
Clinically, it would seem important to ensure that the
living environment of young people is primed to pro-
vide as best a ‘mentalizing culture’ as possible. How
complexity and severity of presentation influences
response to different formats and levels of intensity of
MBT mode of delivery should be tested in future eva-
luations of MBT-A.
Conclusions
Both study procedures and the intervention itself seemed
feasible and acceptable, although a future trial would
benefit from a distinct control condition. Self-reported
self-harm and self-harm related hospital use reduced over
the course of the intervention. In line with mentalization
theory, reflective function was an independent predictor
of reduced self-harm related hospital use at 12 weeks.
Other variables also changed over time in the expected
direction. Future research should seek to inform the
required format and intensity of interventions offered.
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